A study of the inhibitory effects of SCH 28080 on gastric secretion in man. 1982

M D Ene, and T Khan-Daneshmend, and C J Roberts

1 SCH 28080 (2-methyl-8-(phenyl methoxy) imidazo-(1-2-a) pyrine-3-acetonitrile) is a novel drug unrelated to existing anti-ulcer agents. 2 The effect of placebo and increasing doses of the drug on gastric acid output and peptic activity was examined in four healthy men, in the resting state and following pentagastrin stimulation. 3 Significant inhibition of gastric acid secretion and peptic activity occurred with the 50 mg dose in both the stimulated and unstimulated states. Approximately 90% inhibition of acid output was achieved with the 200 mg dose. 4 Antisecretory activity of SCH 28080 is confirmed in man. This drug or an analogue may have potential in anti-ulcer therapy.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D010418 Pentagastrin A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. Acignost,Gastrin Pentapeptide,Peptavlon,Pentapeptide, Gastrin
D005744 Gastric Acid Hydrochloric acid present in GASTRIC JUICE. Hydrochloric Acid, Gastric,Acids, Gastric,Acids, Gastric Hydrochloric,Gastric Acids,Gastric Hydrochloric Acid,Gastric Hydrochloric Acids,Hydrochloric Acids, Gastric
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer

Related Publications

M D Ene, and T Khan-Daneshmend, and C J Roberts
May 1986, British journal of pharmacology,
M D Ene, and T Khan-Daneshmend, and C J Roberts
July 1983, The Journal of pharmacology and experimental therapeutics,
M D Ene, and T Khan-Daneshmend, and C J Roberts
January 1988, Progress in clinical and biological research,
M D Ene, and T Khan-Daneshmend, and C J Roberts
February 1987, The Journal of biological chemistry,
M D Ene, and T Khan-Daneshmend, and C J Roberts
January 1987, Biochemical pharmacology,
M D Ene, and T Khan-Daneshmend, and C J Roberts
January 1993, Renal physiology and biochemistry,
M D Ene, and T Khan-Daneshmend, and C J Roberts
April 1997, Brain research,
M D Ene, and T Khan-Daneshmend, and C J Roberts
July 1987, European journal of pharmacology,
M D Ene, and T Khan-Daneshmend, and C J Roberts
March 1999, The Journal of biological chemistry,
M D Ene, and T Khan-Daneshmend, and C J Roberts
June 1988, Biochemical pharmacology,
Copied contents to your clipboard!